Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1 2

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 151Lung Neoplasms 34Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Neoplasms 9Neoplasm Metastasis 9Mesothelioma 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Thoracic Neoplasms 4Respiratory Tract Neoplasms 4Respiratory Tract Diseases 4Mesothelioma, Malignant 4Lung Diseases 4Carcinoma, Bronchogenic 4Non-squamous Non-small Cell Lung Cancer 3Non-Squamous Non-Small Cell Lung Cancer 3Neoplasms by Site 3NSCLC 3Bronchial Neoplasms 3Adenocarcinoma 3Recurrence 2Non-Squamous Non-small Cell Lung Cancer 2Non Small Cell Lung Carcinoma NSCLC 2Head and Neck Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1

Interventions

Pemetrexed 3Carboplatin 3pembrolizumab 2patritumab 1osimertinib 1napabucasin 1camrelizumab 1aflutinib 1Vinorelbine 1TNFSF10 protein, human 1Paclitaxel 1Injections 1Gemcitabine 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Bronchial Neoplasms × Pemetrexed × Clear all
NCT06119581 2026-05-19

SUNRAY-01

Eli Lilly and Company

Phase 3 Recruiting
1,264 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03402048 2020-11-04

EPIC

University of Turin, Italy

Phase 3 Unknown
567 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03134872 2020-06-09

A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Completed
419 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡